Trial Profile

A phase 3 study of BPL-003 in patients with TRD

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 01 Dec 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

05 Nov 2025 According to an Atai Beckley media release, the ATAI Life Sciences has merged with Beckley Psytech to form Atai Beckley.
05 Nov 2025 According to an atai Life Sciences media release, Cash, cash equivalents, short-term investments and other liquid assets are expected to fund operations into 2029, through anticipated topline data from the first Phase 3 trial of BPL-003
17 Oct 2025 According to an atai Life Sciences media release, company expected to initiate the trial in the second quarter of 2026, subject to alignment with the FDA

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com